---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-23-000020"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2023-05-08T23:59:59+00:00"
generated_at: "2026-06-15T15:15:46.669040+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q1 revenue up 5% to $568.6M; GAAP loss narrows to $(0.41) from $(1.61)

## Summary
- Revenue $568.6M vs $543.1M YoY; GAAP gross margin 34% vs 31%.
- GAAP net loss $(9.8)M ($(0.41)/diluted share) vs $(38.1)M ($(1.61)) a year ago.
- Adjusted diluted EPS $1.74 (down from $1.82); adjusted EBITDA $102.0M vs $84.9M.

## SEC filing metadata
- accession: 0000883984-23-000020
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2023-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398423000020/0000883984-23-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398423000020/icui-20230508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-23-000020
- JSON: https://secwatch.observer/filing/0000883984-23-000020.json
- Plain text: https://secwatch.observer/filing/0000883984-23-000020.txt

## Key facts
- Earnings Releases
  ICU MEDICAL INC/DE reported the quarter ended March 31, 2023 results: revenue $568.6 million, net income $(9.8) million, EPS $(0.41) per diluted share.
  - Period: the quarter ended March 31, 2023
  - Revenue: $568.6 million
  - Net income: $(9.8) million
  - EPS: $(0.41) per diluted share
  - Result: reported results
  source text: First quarter 2023 revenue was $568.6 million, compared to $543.1 million in the same period last year. GAAP gross profit for the first quarter of 2023 was $192.0 million, as compared to $168.8 million in the same period last year. GAAP gross margin for the first quarter of 2023 was 34%, as compared to 31% in the same period last year. GAAP net loss for the first quarter of 2023 was $(9.8) million, or $(0.41) per diluted share, as compared to GAAP net loss of $(38.1) million, or $(1.61) per diluted share, for the first quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883984/000088398423000020/0000883984-23-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.